Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement Of Changes In Shareholder's Equity

v3.21.2
Condensed Statement Of Changes In Shareholder's Equity - 3 months ended Mar. 31, 2021 - USD ($)
Total
Class A Ordinary Shares
Class B Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Balance Beginning at Jan. 12, 2021 $ 0    
Balance Beginning, Shares at Jan. 12, 2021   0 0    
Issuance of Class B Ordinary shares to Sponsor [1] 25,000   $ 1,006 $ 23.994  
Issuance of Class B Ordinary shares to Sponsor, Shares [1]     10,062,500    
Sale of 35,000,000 Units on March 25, 2021 through IPO less fair value of public warrants 341,223,613 $ 3,500   341,220,113  
Sale of 35,000,000 Units on March 25, 2021 through IPO less fair value of public warrants, Shares   35,000,000      
Offering costs (19,347,891)     (19,347,891)  
Net loss (732,339)   $ 733,783   $ (732,339)
Class A ordinary shares subject to possible redemption (316,168,382) $ (3,162)   (316,165,220)  
Class A ordinary shares subject to possible redemption, Shares   (31,616,838)      
Balance Ending at Mar. 31, 2021 $ 5,000,001 $ 338 $ 1,006 $ 5,730,996 $ (732,339)
Balance Ending, Shares at Mar. 31, 2021   3,383,162 10,062,500    
[1] Includes an aggregate of up to 1,312,500 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On April 12, 2021, the underwriters exercised their over-allotment option in full, hence, the Founder Shares were no longer subject to forfeiture (see Note 11).